Tag: biotech stocks to buy
4 Strong Buy Biotech Stocks With Upcoming FDA Decisions
It’s crunch time. These 4 biotechs have what it takes to score crucial regulatory approvals Biotech stocks live and die by FDA decisions. Shares can soar or plunge depending on the FDA decision. Even an approval can spark a selloff if it’s not what investors expect. All four biotech stocks below have a fast-approaching PDUFA date. […]
7 Cheap Biotech Stocks To Buy Now
These biotech stocks are set for a strong comeback as investors walk away from large-cap tech companies U.S equities largely treaded water on Wednesday as Wall Street reacted to legal events and President Trump’s somewhat muted reaction to them. Elsewhere, strong earnings out of the retail sector are helping boost sentiment. The release of the […]
5 Big Biotech Stocks To Buy Under $10
Small biotech stocks can pack a wallop For investors, biotech stocks remain one of the most dynamic sectors out there. On one hand, you have some of the largest pharmaceutical firms on the planet with multi-billion-dollar blockbuster drugs filling their coffers. On the other, you have the more stereotypical “lotto ticket” biotech stocks of clinical […]
5 Cheap Biotech Stocks To Snag On The Bounce
Biotech stocks are on the mend again and these are the five to keep an eye U.S. equities are pushing higher on Friday thanks to a strong non-farm payroll report, the passage of a short-term government funding bill preventing a shutdown tonight and the seasonal tailwinds the bulls enjoy this time of year. One sector […]
4 Must-Own Biotech Stocks As The Sector Comes Charging Back
Up 20% over the last three months, the biotech sector has come roaring back with a vengeance. Given the positive outlook for this sector, Bret Jensen shares his four “must-own” picks through year-end. After three quarters of significantly underperforming the overall market, the biotech sector has roared back in a big way so far in […]
4 Likely Biotech Takeover Targets To Buy
After biotech stock Relypsa was bought out last week for a 60% premium, the odds of M&A heating up in this sector increased dramatically. Bret Jensen shares four more likely takeover targets that should be on your watchlist. It was a good week for the Biotech Gems portfolio. Progenics Pharmaceuticals (NASDAQ: PGNX) leapt 25% in […]
Buy These 4 Undervalued Biotech Stocks On Sale Today
Valuations this cheap haven’t been available in biotech since 2011, and buying any of these four stocks right now could be one of your best investing decisions of 2016. Don’t miss out on the chance to buy these undervalued biotechs that already have commercialized products for what is almost a 50% discount. It has been […]
